Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 30Central Nervous System Neoplasms 18Rectal Neoplasms 15Colorectal Neoplasms 15Lung Neoplasms 13Colonic Neoplasms 11Carcinoma, Non-Small-Cell Lung 11Stomach Neoplasms 9Pancreatic Neoplasms 9Glioblastoma 9Gliosarcoma 7Neoplasm Metastasis 6Esophageal Neoplasms 6Brain Neoplasms 6Adenocarcinoma Of Esophagus 6Carcinoma, Intraductal, Noninfiltrating 5Breast Neoplasms, Male 5Breast Carcinoma In Situ 5Squamous Cell Carcinoma of Head and Neck 4Sarcoma 4Mesothelioma, Malignant 4Kidney Neoplasms 4Head and Neck Neoplasms 4Carcinoma, Renal Cell 4Astrocytoma 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Solitary Fibrous Tumor, Pleural 3Prostatic Neoplasms 3Ovarian Neoplasms 3

Interventions

pembrolizumab 4Nivolumab 4durvalumab 3tremelimumab 1relatlimab 1fludarabine phosphate 1fludarabine 1avelumab 1atezolizumab 1Therapeutics 1Temozolomide 1Surgical Procedures, Operative 1Oxaliplatin 1Neoadjuvant Therapy 1Ipilimumab 1Injections 1Immunoglobulin G 1Docetaxel 1Disulfides 1Cyclophosphamide 1Chemotherapy, Adjuvant 1Capecitabine 1ALT-803 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Microsatellite Instability × Chemotherapy, Adjuvant × Clear all
NCT06646445 2025-06-13

PREMICES

GERCOR - Multidisciplinary Oncology Cooperative Group

Phase 2 Not yet recruiting
60 enrolled
Gastrointestinal

Turcot syndrome, Colonic Neoplasms, Microsatellite Instability

Data powered by HemOnc (CC BY 4.0) Colophon âš¡